Anika Therapeutics Inc
NASDAQ:ANIK
Intrinsic Value
The intrinsic value of one
ANIK
stock under the Base Case scenario is
25.896
USD.
Compared to the current market price of 9.995 USD,
Anika Therapeutics Inc
is
Undervalued by 61%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Anika Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Anika Therapeutics Inc
Balance Sheet Decomposition
Anika Therapeutics Inc
| Current Assets | 99.3m |
| Cash & Short-Term Investments | 53.2m |
| Receivables | 24m |
| Other Current Assets | 22.2m |
| Non-Current Assets | 88.4m |
| PP&E | 65.8m |
| Intangibles | 9.7m |
| Other Non-Current Assets | 12.8m |
Free Cash Flow Analysis
Anika Therapeutics Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Anika Therapeutics Inc
|
Revenue
|
123.7m
USD
|
|
Cost of Revenue
|
-53.4m
USD
|
|
Gross Profit
|
70.3m
USD
|
|
Operating Expenses
|
-81.2m
USD
|
|
Operating Income
|
-10.9m
USD
|
|
Other Expenses
|
-49.7m
USD
|
|
Net Income
|
-60.6m
USD
|
ANIK Profitability Score
Profitability Due Diligence
Anika Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Anika Therapeutics Inc's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
ANIK Solvency Score
Solvency Due Diligence
Anika Therapeutics Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Anika Therapeutics Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ANIK Price Targets Summary
Anika Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
ANIK
is 16.32 USD
with a low forecast of 16.16 USD and a high forecast of 16.8 USD.
Dividends
Current shareholder yield for
ANIK is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
ANIK
stock under the Base Case scenario is
25.896
USD.
Compared to the current market price of 9.995 USD,
Anika Therapeutics Inc
is
Undervalued by 61%.